Formation | 2015 |
---|---|
Headquarters | Vaccine and Infectious Disease Institute of the University of Antwerp |
Website | Official website |
The HPV Prevention and Control Board, founded in 2015, is an independent group of international experts supported by unrestricted grants from the pharmaceutical industry[3] that bring together key professionals, groups and government officials to deal with issues related to screening and prevention programmes for human papillomavirus (HPV) infection, the persistence of which may lead to cervical cancer, the second most common cancer in women living in low-resource settings.[1][4][5] The Board focusses on preventing cervical cancer in these countries by promoting the sharing of information on cervical screening and HPV vaccination, which by 2014 had reached only around 3% of eligible girls in low income countries.[4][5][6]
The Board is located at the Vaccine and Infectious Disease Institute of the University of Antwerp and its website is a member of the World Health Organization (WHO) led project Vaccine Safety Net (VSN).[7]
Local policy-makers can take advice and assistance from the Board on introducing and extending programmes, and by taking into consideration recommendations by the WHO, the Board can facilitate political backing required for their application.[8] One example of their work was in 2018 when the Board contributed to efforts to regain confidence in vaccines for cervical cancer in Columbia following a sudden nationwide drop in uptake of the vaccine's first and second dose from 98% and 88% in 2012 to 14% and 5% in 2016.[9]
Stanley
was invoked but never defined (see the help page).Wittet
was invoked but never defined (see the help page).Bruni
was invoked but never defined (see the help page).WHO
was invoked but never defined (see the help page).Vorsters2017
was invoked but never defined (see the help page).HPVworld
was invoked but never defined (see the help page).